<DOC>
	<DOCNO>NCT00288210</DOCNO>
	<brief_summary>The incidence stent restenosis set primary angioplasty particularly high , reach rate 27 % In last year introduction drug-eluting stent drastically reduce incidence restenosis patient require urgent revascularization . Whether drug-eluting stenting might constitute new optimal therapy patient acute myocardial infarction unknown . To able answer question , design randomized trial patient acute myocardial infarction eligible treatment primary angioplasty abciximab randomize receive either rapamicine-eluting stent conventional bare stent .</brief_summary>
	<brief_title>Sirolimus Eluting Stenting Acute Myocardial Infarction</brief_title>
	<detailed_description>The treatment acute myocardial infarction evolve dramatically last decade . Coronary angioplasty stent implantation conjunction optimal antitrombotic therapy abciximab consider current standard therapy However , incidence stent restenosis set primary angioplasty remain particularly high , reach rate 27 % . A high restenosis rate cause high re-hospitalization rate target vessel revascularization ensue increase cost.In last year introduction drug-eluting stent drastically reduce incidence restenosis patient require urgent revascularization . This reduced incidence restenosis occur without increase adverse clinical event conventional stent low rate stent subacute thrombosis . Whether combination drug-eluting stent abciximab might constitute new optimal therapy patient acute myocardial infarction unknown . To able answer question , design one year coronary angiographic study patient acute myocardial infarction eligible treatment primary angioplasty abciximab randomize receive either rapamicine-eluting stent conventional bare stent .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion criterion age 18 year , presence least 30 minute less 12 hour symptoms consistent acute myocardial infarction , presence STsegment elevation least two contiguous lead leave bundlebranch block . Patients exclude cardiogenic shock ( define systolic blood pressure le 80 mm Hg 30 minute need intravenous pressor intraaorticballoon counterpulsation ) ; history bleeding diathesis ; history leukopenia , thrombocytopenia , severe hepatic renal dysfunction ; noncardiac illness associate life expectancy le one year ; participate another study ; unable give inform consent owe prolonged cardiopulmonary resuscitation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Stents</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>abciximab</keyword>
</DOC>